(Q37461431)

English

Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis

scientific article published on May 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

Antimicrobial dosing concepts and recommendations for critically ill adult patients receiving continuous renal replacement therapy or intermittent hemodialysis (English)

1 reference

Europe PubMed Central

20 August 2017

0 references

hemodialysis patient

1 reference

based on heuristic

inferred from title

author name string

Brett H Heintz

1

1 reference

Europe PubMed Central

20 August 2017

Gary R Matzke

2

1 reference

Europe PubMed Central

20 August 2017

William E Dager

3

1 reference

Europe PubMed Central

20 August 2017

language of work or name

0 references

publication date

1 May 2009

1 reference

Europe PubMed Central

20 August 2017

Pharmacotherapy

1 reference

Europe PubMed Central

20 August 2017

29

1 reference

Europe PubMed Central

20 August 2017

5

1 reference

Europe PubMed Central

20 August 2017

562-577

1 reference

Europe PubMed Central

20 August 2017

Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Impact of adequate empirical antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Timing of replacement therapy for acute renal failure after cardiac surgery

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Renal replacement therapy and the kidney: minimizing the impact of renal replacement therapy on recovery of acute renal failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Incidence and mortality of acute renal failure in Medicare beneficiaries, 1992 to 2001.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Acute renal failure in intensive care units--causes, outcome, and prognostic factors of hospital mortality; a prospective, multicenter study. French Study Group on Acute Renal Failure.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Acute renal failure in the ICU: risk factors and outcome evaluated by the SOFA score

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Drug-associated renal dysfunction.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacist participation on physician rounds and adverse drug events in the intensive care unit

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Influence of renal function on the pharmacokinetics of piperacillin/tazobactam in intensive care unit patients during continuous venovenous hemofiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics of meropenem in patients with renal failure and patients receiving renal replacement therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Gastrointestinal parameters that influence oral medications

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Altered nonrenal drug clearance in ESRD.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Emerging evidence of the impact of kidney disease on drug metabolism and transport

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Effect of hemodialysis on hepatic cytochrome P450 functional expression

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Down-regulation of hepatic cytochrome p450 in chronic renal failure: role of uremic mediators

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetic changes in critical illness

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetic and pharmacodynamic considerations when treating patients with sepsis and septic shock

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Antimicrobial therapy in critically ill patients: a review of pathophysiological conditions responsible for altered disposition and pharmacokinetic variability

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Drug dosing in continuous renal replacement therapy: general rules

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacodynamics: relation to antimicrobial resistance

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Application of antimicrobial pharmacodynamic concepts into clinical practice: focus on beta-lactam antibiotics: insights from the Society of Infectious Diseases Pharmacists

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Antibiotic dosing in critically ill adult patients receiving continuous renal replacement therapy

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

A primer on continuous renal replacement therapy for critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Continuous infusion of ceftazidime in critically ill patients undergoing continuous venovenous haemodiafiltration: pharmacokinetic evaluation and dose recommendation

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics of colistin methanesulfonate and colistin in a critically ill patient receiving continuous venovenous hemodiafiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Fluconazole dosing in continuous veno-venous haemofiltration (CVVHF): need for a high daily dose of 800 mg.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics and the most suitable dosing regimen of fluconazole in critically ill patients receiving continuous hemodiafiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Influence of hemodialysis on gentamicin pharmacokinetics, removal during hemodialysis, and recommended dosing

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Correlation of meropenem plasma levels with pharmacodynamic requirements in critically ill patients receiving continuous veno-venous hemofiltration

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics and dosage adaptation of meropenem during continuous venovenous hemodiafiltration in critically ill patients.

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Adequacy of a vancomycin dosing regimen in patients receiving high-flux hemodialysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Clinical review: use of vancomycin in haemodialysis patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Vancomycin use in patients requiring hemodialysis: a literature review

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Pharmacokinetics and drug dosing adjustments during continuous venovenous hemofiltration or hemodiafiltration in critically ill patients

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Filtering out important considerations for developing drug-dosing regimens in extended daily dialysis

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Adjustment of Antimicrobial Dosages for Continuous Venovenous Hemofiltration Based on Patient-Specific Information

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.29.5.562

21 January 2018

Identifiers

10.1592/PHCO.29.5.562

1 reference

Europe PubMed Central

20 August 2017

1 reference

Europe PubMed Central

20 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37461431&oldid=2165107242"